NewsJanuary 19
Changes in Corporate Officer Areas of Responsibility at PHC Holdings Corporation Effective January 19, 2022
Please be advised of the changes in the following Corporate Officers’ areas of responsibility at PHC Holdings Corporation effective January 19, 2022.
(1) Changes to the Roles and Responsibilities on January 19, 2022
| Name |
Until Jan 18, 2022 |
From Jan 19, 2022 |
| Ryuichi Hirashima |
Corporate Officer,
Chief Strategic Officer (CSO)
In Charge of Corporate Planning/Business
Development/External Affairs
|
Corporate Officer,
Chief Transformation Officer (CTO)・EVP
|
| Kaiju Yamaguchi |
Corporate Officer,
(concurrent assignment as)
General Manager,
Corporate Planning Department
|
Corporate Officer,
SVP, Corporate Development & Investor Relations
|
(2) Board of Directors and Corporate Officers at PHC Holdings Corporation on January 19, 2022
Members of Board, Audit and Supervisory Board Members
| Position/Title |
Name |
Remarks |
President,
Member of Board |
John Marotta |
|
Executive Vice President,
Member of Board |
Shoji Miyazaki |
Director (part-time),
PHC Corporation
|
Director,
Member of Board |
Hirofumi Hirano |
Chief Executive Officer,
KKR Japan Limited |
Director,
Member of Board |
Koichiro Sato |
MBK HEALTHCARE MANAGEMENT PTE. LTD.
Hong Kong Branch, CEO |
Director,
Member of Board |
Tatsunobu Fukushima |
General Manager,
Corporate Planning Department
Life Science Institute, Inc. |
Director,
Member of Board
(Lead Independent External Director) |
Alan Malus |
|
Director,
Member of Board
(Independent External Director) |
Kyoko Deguchi |
|
Director,
Member of Board
(Independent External Director) |
William Donnelly |
|
Director,
Member of Board
(Independent External Director) |
Ivan Tornos |
|
Audit and Supervisory
Board Member |
Koichi Ikeuchi |
Audit and Supervisory
Board Member,
PHC Corporation |
Audit and Supervisory
Board Member
(Independent External Audit and
Supervisory Board Member) |
Noriaki Yamada |
Representative Partner,
Clifix Certified Public Tax
Accountant’s Corporation |
Audit and Supervisory
Board Member
(Independent External Audit and
Supervisory Board Member) |
Shannon Hansen |
|
Corporate Officers
| Position/Title |
Name |
Remarks |
| Chief Executive Officer (CEO) |
John Marotta |
President |
Chief Operating Officer (COO)
In Charge of Risk Management |
Shoji Miyazaki |
Executive Vice President
Director (part-time), PHC Corporation |
Corporate Officer,
Chief Financial Officer (CFO) |
Frederick Reidenbach |
|
Corporate Officer,
Chief Transformation Officer (CTO)・EVP
|
Ryuichi Hirashima |
|
Corporate Officer,
Head of Diabetes Management Domain |
Robert Schumm |
President,
Ascensia Diabetes Care Holdings AG |
Corporate Officer,
In Charge of Engineering/Manufacturing |
Kyoji Morimoto |
President,
PHC Corporation |
Corporate Officer,
Co-head of Life Sciences/Diagnostics Domain |
Nobuaki Nakamura |
Director, Member of Board
Biomedical Division, PHC Corporation |
Corporate Officer,
Co-head of Healthcare Solutions Domain |
Takayuki Otsuka |
Director, Member of Board
Medical Information Systems Division,
PHC Corporation |
Corporate Officer,
Co-head of Healthcare Solutions Domain |
Haruo Watanabe |
President and Chief Executive Officer,
LSI Medience Corporation |
Corporate Officer,
General Counsel |
Ephraim Starr |
|
Corporate Officer,
Chief Human Resources Officer (CHRO) |
Jon Ebina |
|
Corporate Officer,
Co-head of Life Sciences/Diagnostics Domain |
John Sweeney |
President, Epredia |
Corporate Officer,
SVP, Corporate Development & Investor Relations |
Kaiju Yamaguchi |
|